207 related articles for article (PubMed ID: 24782431)
1. Small-molecule proteomimetic inhibitors of the HIF-1α-p300 protein-protein interaction.
Burslem GM; Kyle HF; Breeze AL; Edwards TA; Nelson A; Warriner SL; Wilson AJ
Chembiochem; 2014 May; 15(8):1083-7. PubMed ID: 24782431
[TBL] [Abstract][Full Text] [Related]
2. Towards "bionic" proteins: replacement of continuous sequences from HIF-1α with proteomimetics to create functional p300 binding HIF-1α mimics.
Burslem GM; Kyle HF; Breeze AL; Edwards TA; Nelson A; Warriner SL; Wilson AJ
Chem Commun (Camb); 2016 Apr; 52(31):5421-4. PubMed ID: 27009828
[TBL] [Abstract][Full Text] [Related]
3. Insights from molecular dynamics simulations and steered molecular dynamics simulations to exploit new trends of the interaction between HIF-1α and p300.
Yu Z; Liu Y; Zhu J; Han J; Tian X; Han W; Zhao L
J Biomol Struct Dyn; 2020 Jan; 38(1):1-12. PubMed ID: 30784357
[TBL] [Abstract][Full Text] [Related]
4. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
Na YR; Han KC; Park H; Yang EG
Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
[TBL] [Abstract][Full Text] [Related]
5. Structural Elucidation and Synthesis of Eudistidine A: An Unusual Polycyclic Marine Alkaloid that Blocks Interaction of the Protein Binding Domains of p300 and HIF-1α.
Chan ST; Patel PR; Ransom TR; Henrich CJ; McKee TC; Goey AK; Cook KM; Figg WD; McMahon JB; Schnermann MJ; Gustafson KR
J Am Chem Soc; 2015 Apr; 137(16):5569-75. PubMed ID: 25892103
[TBL] [Abstract][Full Text] [Related]
6. Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction.
Yang C; Wang W; Li GD; Zhong HJ; Dong ZZ; Wong CY; Kwong DW; Ma DL; Leung CH
Sci Rep; 2017 Feb; 7():42860. PubMed ID: 28225008
[TBL] [Abstract][Full Text] [Related]
7. Modulation of p300 binding by posttranslational modifications of the C-terminal activation domain of hypoxia-inducible factor-1alpha.
Cho H; Ahn DR; Park H; Yang EG
FEBS Lett; 2007 Apr; 581(8):1542-8. PubMed ID: 17382325
[TBL] [Abstract][Full Text] [Related]
8. Visualization of hypoxia-inducible factor 1α-p300 interactions in live cells by fluorescence resonance energy transfer.
Kim SY; Lee MJ; Na YR; Kim SY; Yang EG
J Cell Biochem; 2014 Feb; 115(2):271-80. PubMed ID: 23966271
[TBL] [Abstract][Full Text] [Related]
9. Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.
Ruas JL; Berchner-Pfannschmidt U; Malik S; Gradin K; Fandrey J; Roeder RG; Pereira T; Poellinger L
J Biol Chem; 2010 Jan; 285(4):2601-9. PubMed ID: 19880525
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1α-p300 interaction by a small molecule.
Kwon HS; Kim DR; Yang EG; Park YK; Ahn HC; Min SJ; Ahn DR
Bioorg Med Chem Lett; 2012 Aug; 22(16):5249-52. PubMed ID: 22789427
[TBL] [Abstract][Full Text] [Related]
11. Exploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologies.
Kyle HF; Wickson KF; Stott J; Burslem GM; Breeze AL; Tiede C; Tomlinson DC; Warriner SL; Nelson A; Wilson AJ; Edwards TA
Mol Biosyst; 2015 Oct; 11(10):2738-49. PubMed ID: 26135796
[TBL] [Abstract][Full Text] [Related]
12. Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.
Li J; Xi W; Li X; Sun H; Li Y
Bioorg Med Chem; 2019 Apr; 27(7):1145-1158. PubMed ID: 30819620
[TBL] [Abstract][Full Text] [Related]
13. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
Yoon H; Lim JH; Cho CH; Huang LE; Park JW
Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Binding Affinity Analysis, and
Dawn Woodfield J; Bhardwaj A; Bergman C; Wuest F
ChemMedChem; 2022 Jan; 17(1):e202100544. PubMed ID: 34595843
[TBL] [Abstract][Full Text] [Related]
15. Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interaction.
Cardoso R; Love R; Nilsson CL; Bergqvist S; Nowlin D; Yan J; Liu KK; Zhu J; Chen P; Deng YL; Dyson HJ; Greig MJ; Brooun A
Protein Sci; 2012 Dec; 21(12):1885-96. PubMed ID: 23033253
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II).
Jayatunga MK; Thompson S; McKee TC; Chan MC; Reece KM; Hardy AP; Sekirnik R; Seden PT; Cook KM; McMahon JB; Figg WD; Schofield CJ; Hamilton AD
Eur J Med Chem; 2015 Apr; 94():509-16. PubMed ID: 25023609
[TBL] [Abstract][Full Text] [Related]
17. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
[TBL] [Abstract][Full Text] [Related]
18. Multivalent helix mimetics for PPI-inhibition.
Barnard A; Miles JA; Burslem GM; Barker AM; Wilson AJ
Org Biomol Chem; 2015 Jan; 13(1):258-64. PubMed ID: 25408290
[TBL] [Abstract][Full Text] [Related]
19. A novel function of novobiocin: disrupting the interaction of HIF 1α and p300/CBP through direct binding to the HIF1α C-terminal activation domain.
Wu D; Zhang R; Zhao R; Chen G; Cai Y; Jin J
PLoS One; 2013; 8(5):e62014. PubMed ID: 23671581
[TBL] [Abstract][Full Text] [Related]
20. NF-κB suppresses HIF-1α response by competing for P300 binding.
Mendonça DB; Mendonça G; Aragão FJ; Cooper LF
Biochem Biophys Res Commun; 2011 Jan; 404(4):997-1003. PubMed ID: 21187066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
